CC-SP | BC-SP | CRC-SP | |
---|---|---|---|
Since (year) | 1979 (pilots from 1976) | 1990 (pilots from 1984) | 2014 (fully operational since 2019) |
Population | |||
Age boundaries | 30–60 | 50–75 | 55–75 |
Sex | F | F | F & M |
Interval (years) | 5 | 2 | 2 |
Screening test | HPV-test, if HPV positive then cytology (Pap-smear) | Mammography (bilateral) | Faecal Immunochemical Test (FIT) |
General practitioner involvement | Performing pap-smear, discuss outcome, hospital referrala | Discuss outcome, hospital referralb | Nonec; discuss outcome |
Screening outcome | HPV absent, present or unclear (re-testing). When applicable Pap-classification and HPV-typology. | Abnormality absent, abnormality present, not enough information (BI-RADS-code 0–5) | Negative (no examination needed), positive (examination needed), unclear (re-testing) |
Financing | |||
Invitation, screening test(s) and analyses | Dutch government | ||
Secondary test(s) and treatment | Standard healthcare, hence depending on one’s individual insurance policy |